Wells Fargo
OKUR

Wells Fargo’s OnKure Therapeutics OKUR Stock Holding History

Wells Fargo’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
36,451
+22,951
+170% +$98.5K ﹤0.01% 5304
2026
Q1 		$55.9K Buy
13,500
+2,500
+23% +$7.72K ﹤0.01% 5420
2025
Q4 		$31.9K Buy
11,000
+1,500
+16% +$4.49K ﹤0.01% 5676
2025
Q3 		$26.1K Buy
9,500
+1,880
+25% +$4.66K ﹤0.01% 5732
2025
Q2 		$18.2K Buy
7,620
+4,000
+110% +$10.5K ﹤0.01% 5807
2025
Q1 		$15.6K Buy
3,620
+2,000
+123% +$11.2K ﹤0.01% 5775
2024
Q4 		$13.9K Buy
1,620
+1,500
+1,250% +$22.7K ﹤0.01% 5855
2024
Q3 		$2.04K Hold
120
– – ﹤0.01% 6053
2024
Q2 		$1.81K Sell
120
-412
-77% -$6.98K ﹤0.01% 6030
2024
Q1 		$8.84K Buy
532
+50
+10% +$825 ﹤0.01% 5791
2023
Q4 		$7.71K Buy
482
+24
+5% +$1.5K ﹤0.01% 5895
2023
Q3 		$34.9K Sell
458
-114
-20% -$7.75K ﹤0.01% 5364
2023
Q2 		$37.5K Buy
572
+446
+354% +$35.9K ﹤0.01% 5539
2023
Q1 		$7.56K Hold
126
– – ﹤0.01% 5939
2022
Q4 		$2.94K Hold
126
– – ﹤0.01% 5913
2022
Q3 		$4K Buy
126
+2
+2% +$66 ﹤0.01% 5996
2022
Q2 		$3K Sell
124
-412
-77% -$9.59K ﹤0.01% 6244
2022
Q1 		$16K Sell
536
-262
-33% -$14.7K ﹤0.01% 6110
2021
Q4 		$68K Buy
+798
New +$58.6K ﹤0.01% 5828

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wells Fargo's OKUR Position: Q2 2026 in Review

Wells Fargo increased its OnKure Therapeutics (OKUR) stake by 170% in Q2 2026, buying an estimated $98.5K and bringing the position to 36,451 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #5304.

Wells Fargo first reported a position in OKUR in Q4 2021 and has held it in 19 quarters since. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Wells Fargo held 36,451 shares of OnKure Therapeutics worth $166K as of Q2 2026.
  • Wells Fargo bought 22,951 OnKure Therapeutics shares in Q2 2026, an estimated $98.5K.
  • OnKure Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5304 holding.
  • Wells Fargo first reported a position in OnKure Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.